Anaemia
97
2
2
79
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
24 trials with published results (25%)
Research Maturity
79 completed trials (81% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.2%
6 terminated out of 97 trials
92.9%
+6.4% vs benchmark
33%
32 trials in Phase 3/4
30%
24 of 79 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 79 completed trials
Clinical Trials (97)
Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study
The Effect of an Oral Nutritional Supplement on the Nutritional and Health Outcomes of the Elderly
Transfusion Practices in Intensive Care Units: a Hungarian Nationwide Survey
Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery
A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.
Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard
Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)
Correction of Anaemia and Progression of Renal Failure on Transplanted Patients
South African Paediatric Surgical Outcomes Study 2
Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.
the MCCE vs EGD Trial
Burden of Schistosomiasis and Soil-transmitted Helminth Infections in Schoolchildren in Banfora, Burkina Faso
Comparison of Daprodustat Formulations Produced by Two Methods of Manufacture for Bioequivalence and Dissolution in Healthy Participants
Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics
Efficacy of Three Novel Bi-treated Long Lasting Insecticidal Nets
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)